The key is "as soon as possible", not after the trial is complete and results using new endpoints announced. If they changed on January 18th, why not explain then? Better yet, if they planned on new endpoints based on FDA guidance at the beginning of the trial, update trial design then and announce why you are doing it. These are simple things... if they can't handle the simple things, what else is going on?